CCO Expert Recap

Report on Antiretroviral Therapy

Source: CCO Independent Conference Coverage of the 2005 Conference on Retroviruses and Opportunistic Infections*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Report on Antiretroviral Therapy

Program Director: John P. Phair, MD

Faculty:

Joel E. Gallant, MD, MPH

CME CREDIT INFORMATION

Release Date: 04/05/05

Expiration Date: 04/04/06

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Recount data regarding the prevalence of transmitted drug resistance and rapid progression to AIDS and factors contributing to their incidence
Discuss differences and similarities between first-line antiretroviral regimens, and special considerations for developed and developing countries
Review treatment strategies for experienced patients, including use of newer and investigational antiretroviral agents and pre-salvage therapy treatment interruption

CCO Expert Recap combining slides with audio commentary by Joel E. Gallant, MD, MPH. Topics covered include:

Initial Antiretroviral Therapy
Management of Treatment-Experienced Patients
Resistance
Novel Antiretroviral Agents

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.